Avalo Therapeutics Ownership | Who Owns Avalo Therapeutics?
Avalo Therapeutics Ownership Summary
Avalo Therapeutics is owned by 162.61% institutional investors, 1.69% insiders. Fmr is the largest institutional shareholder, holding 21.48% of AVTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 6.27% of its assets in Avalo Therapeutics shares.
AVTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Avalo Therapeutics | 162.61% | 1.69% | -64.29% |
| Sector | Healthcare Stocks | 245.07% | 12.10% | -157.17% |
| Industry | Biotech Stocks | 380.48% | 11.73% | -292.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 2.88M | 21.48% | $42.99M |
| Caligan partners lp | 1.64M | 12.20% | $24.41M |
| Bvf inc/il | 1.63M | 12.18% | $24.38M |
| Avoro capital advisors | 1.41M | 10.52% | $21.05M |
| Affinity asset advisors | 1.34M | 10.00% | $20.02M |
| Nantahala capital management | 1.24M | 9.21% | $18.44M |
| Ubs group | 1.14M | 8.52% | $17.05M |
| Point72 asset management | 916.14K | 6.83% | $13.68M |
| Farallon capital management | 916.00K | 6.83% | $13.68M |
| Rtw investments, lp | 856.96K | 6.39% | $12.79M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Velan capital investment management lp | 185.12K | 1.73% | $2.76M |
| Caligan partners lp | 1.64M | 1.62% | $24.41M |
| Pivotal bioventure partners investment advisor | 295.93K | 1.58% | $4.42M |
| Ally bridge group (ny) | 178.10K | 1.38% | $2.26M |
| Affinity asset advisors | 1.34M | 1.03% | $20.02M |
| Bvf inc/il | 1.63M | 0.78% | $24.38M |
| Nantahala capital management | 1.24M | 0.68% | $18.44M |
| Acuta capital partners | 60.81K | 0.64% | $907.86K |
| Boxer capital management | 300.00K | 0.59% | $4.48M |
| Allostery investments lp | 9.00K | 0.57% | $44.91K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 2.88M | 0.00% | 2.66M |
| Avoro capital advisors | 1.41M | 0.21% | 1.41M |
| Farallon capital management | 916.00K | 0.08% | 916.00K |
| Rtw investments, lp | 856.96K | 0.13% | 856.96K |
| Caligan partners lp | 1.64M | 1.62% | 753.49K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| T. rowe price investment management | - | - | -2.16M |
| Millennium management | - | - | -835.48K |
| Silverarc capital management | - | - | -524.44K |
| Orbimed advisors | - | - | -475.17K |
| Jennison associates | - | - | -470.77K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Avoro capital advisors | 1.41M | 0.21% | 1.41M | $21.05M |
| Farallon capital management | 916.00K | 0.08% | 916.00K | $13.68M |
| Rtw investments, lp | 856.96K | 0.13% | 856.96K | $12.79M |
| Logos global management lp | 300.00K | 0.22% | 300.00K | $4.48M |
| Pivotal bioventure partners investment advisor | 295.93K | 1.58% | 295.93K | $4.42M |
Sold Out
| Holder | Change |
|---|---|
| Group one trading | -1.00 |
| Raymond james financial | -1.00 |
| Sbi securities | -23.00 |
| Farther finance advisors | -75.00 |
| Simplex trading | -748.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 136 | 24.77% | 70,899,495 | 127.94% | 162 | 0.68% | 103 | 58.46% | 19 | -13.64% |
| Mar 31, 2026 | 22 | -76.34% | 3,244,082 | -83.69% | 24 | 0.12% | 14 | -77.42% | 2 | -84.62% |
| Dec 31, 2025 | 41 | -41.43% | 8,217,986 | -46.35% | 58 | 0.29% | 30 | -36.17% | 4 | -50.00% |
| Sep 30, 2025 | 69 | 97.14% | 14,834,685 | 89.14% | 136 | 2.61% | 47 | 261.54% | 8 | -33.33% |
| Jun 30, 2025 | 35 | 6.06% | 7,843,040 | -4.99% | 72 | 1.18% | 13 | -13.33% | 12 | 200.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.68M | 6.27% | 195.40K |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.68M | 3.17% | 195.40K |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.68M | 3.12% | - |
| State Street® SPDR® S&P® Biotech ETF | 1.51M | 2.81% | 16.98K |
| T. Rowe Price US Small-Cap Core Equity | 678.82K | 2.77% | 678.82K |
| T. Rowe Price Small-Cap Stock | 678.34K | 2.54% | -483.00 |
| FIAM Small Cap Core Composite | 670.70K | 2.51% | 670.70K |
| iShares Russell 2000 ETF | 1.34M | 2.49% | 11.42K |
| Fidelity Stock Selector Small Cap | 1.21M | 2.26% | 2.70K |
| T. Rowe Price Small-Cap Value | 588.42K | 2.20% | 209.33K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 16, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sell | $202.44K |
| Sep 10, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sell | $179.46K |
| Aug 28, 2026 | Doyle Mittie | Chief Medical Officer | Sell | $13.58K |
| Aug 17, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sell | $74.76K |
| Aug 18, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | Sell | $622.32K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 10 |
| 2026 Q2 | - | 30 |
| 2026 Q1 | - | 1 |
| 2025 Q4 | - | 2 |
| 2025 Q3 | - | - |
AVTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools